In this issue:
Stem cell-derived, fully differentiated islets for type 1 diabetes
Fracture risk in diabetes
Thyroid tumour risk with GLP-1 agonists
Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa
Semaglutide ± MRA in type 2 diabetes and CKD
Early electronic specialist-led diabetes care improves postdischarge glycaemia
Semaglutide in symptomatic PAD according to type 2 diabetes characteristics
Associations of HbA1c with complications in diabetes with severe CKD
Hypercortisolism in difficult-to-control type 2 diabetes
Ecnoglutide vs. dulaglutide in type 2 diabetes
Please login below to download this issue (PDF)